Arrhythmogenic cardiomyopathy

Arrhythmogenic cardiomyopathy is a genetic disease that is manifested clinically with ventricular arrhythmias between the ages of 20 and 50. There is no single ‘standard’ for the diagnosis that needs to be based on a combination of electrical structural and genetic abnormalities. Two-dimensional echocardiography is the usual imaging modality that is preferred in patients suspected of the disease, but cardiovascular magnetic resonance has the advantage of quantitative assessment of right and left ventricular function, as well as being more precise in evaluating cardiac wall motion abnormalities. Other imaging modalities, such as three-dimensional echocardiography and cardiac computed tomography scanning, are promising diagnostic techniques in identifying those individuals who present with dominant left ventricular involvement.